Live Webinar: First-line and Switch Strategies Using Current ART Regimens, and COVID-19 Update

Join 3 leading experts for an interactive Webinar providing a brief regional update on COVID-19 and HIV management followed by an engaging case-based discussion on optimizing the use of current ART regimens for initial HIV treatment and switch strategies for patients with viral suppression but who require a change in therapy.

June 18, 2020 at 3:00 PM – For clinicians in Florida
June 18, 2020 at 6:00 PM – For clinicians in the Midwest
June 23, 2020 at 12:00 PM – For clinicians in New England
June 23, 2020 at 12:00 PM – For clinicians in Western US
June 23, 2020 at 4:00 PM – For clinicians in the Carolinas
June 24, 2020 at 3:00 PM – For clinicians in New Jersey / Delaware
June 24, 2020 at 6:00 PM – For clinicians in the Delta region
July 1, 2020 at 12:00 PM – For clinicians in the South
July 2, 2020 at 12:00 PM – For clinicians in Pennsylvania
July 2, 2020 at 3:00 PM – For clinicians in Northeastern US


The timing and agenda for each webinar is as follows:

  • Introduction and Program Overview (5 mins)
  • COVID-19 and HIV: Regional Update (10-15 mins)
  • Case-Based Discussion (55-60 mins)
    • Choosing ART for a newly diagnosed person
    • Switching ART in virologically suppressed persons
  • Question and Answer Session (15 mins)


Program Director
Joseph J. Eron, MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Program Director
Princy N. Kumar, MD

Professor of Medicine and Microbiology
Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Jonathan Appelbaum, MD

Laurie L. Dozier Jr, MD, Education Director
Professor of Internal Medicine
Department of Clinical Sciences
Florida State University College of Medicine
Tallahassee, Florida

Roger Bedimo, MD

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

Jason Halperin, MD, MPH

Assistant Professor of Medicine
Department of Infectious Diseases
Tulane University
Infectious Disease Physician
New Orleans, Louisiana

W. David Hardy, MD

Scientific and Medical Consultant
Adjunct Professor of Medicine

Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Daniel R. Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Karam Mounzer, MD

Clinical Professor of Medicine
Department of Internal Medicine and Infectious Disease
University of Pennsylvania
Chief Scientific Officer
Philadelphia FIGHT
Philadelphia, Pennsylvania

Renslow Sherer, MD

Director, International HIV Training Center
Professor of Medicine
University of Chicago
Chicago, Illinois

Shobha Swaminathan, MD

Associate Professor
Division of Infectious Diseases
Department of Medicine
Rutgers New Jersey Medical School
Newark, New Jersey

Alan Taege, MD

Assistant Professor of Medicine
Department of Medicine
Cleveland Clinic Lerner College of Medicine
Staff Physician
Department of Infectious Disease
Cleveland Clinic
Cleveland, Ohio

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader,  AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director, HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

Goal Statement
The goal of this activity is to improve learners’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for physicians, registered nurses, physician assistants, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate best practices when selecting first-line ARV regimens for HIV-infected patients
  • Identify patients who are candidates for modifying a virologically suppressive regimen to achieve specific benefits associated with newer agents and regimens
  • Apply appropriate treatment modification strategies for patients already receiving ART who are virologically suppressed


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity or enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Continuing Pharmacy Education
CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-20-007-L02-P

Activity type: Application

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.